On ECHEMI
Home > Drugs > Mixed sugar electrolyte injection

Mixed sugar electrolyte injection

Function and Efficacy

1. Tests using fasting white rabbits showed that compared with 7.5% glucose electrolyte infusion, this product significantly reduced total blood ketone bodies and significantly increased liver glycogen. The mixed glucose, fructose and xylitol in this product can be effectively utilized in the body. At the same time, the one-time water balance is positive, and the electrolyte balance is maintained or reduced to a negative balance. 2. Tests using diabetic rats with moderate surgical invasion load showed that compared with 10% glucose electrolyte infusion, this product significantly reduced blood glucose concentration and total sugar excretion rate in urine after surgery, and sugar utilization was very good even when glucose tolerance was reduced.

Ingredients

Sodium Calcium

Appearance

This product is a colorless or almost colorless clear liquid with a sweet taste.

Indication

When oral administration is not possible or the oral administration is insufficient, replenish and maintain water and electrolytes, and supply energy.

Usage and Dosage

Slow intravenous drip. Usually, adults take 500-1000 ml each time. The administration rate (calculated as glucose) should not exceed 0.5 g/kg body weight per hour for adults. It can be increased or decreased according to age, symptoms, body weight and other conditions.

Adverse Reactions

When side effects are found, appropriate treatment measures such as discontinuation of administration should be taken. Type/frequency 5% or more or unknown frequency less than 1-5% 1. Allergic reaction: rash; 2. Rapid administration of large amounts: cerebral edema, emphysema, peripheral edema, water intoxication, hyperkalemia, vasculitis, liver dysfunction and renal dysfunction; 3. Others: vascular pain.

Precautions

1. Patients with severe liver dysfunction and severe renal dysfunction; 2. Patients with abnormal electrolyte metabolism: (1) Patients with hyperkalemia (oliguria, adrenal cortex insufficiency, severe burns and azotemia, etc.); (2) Patients with hypercalcemia; (3) Patients with hyperphosphatemia; (4) Patients with hypermagnesemia. 3. Patients with hereditary fructose intolerance.

Special Population Medication

Precautions for children: This experiment has not been conducted and there is no reliable reference. Precautions for pregnancy and lactation: This experiment has not been conducted and there is no reliable reference.

Drug Interactions

This experiment has not been conducted and there are no reliable references.

Storage

Room temperature and away from light

Packaging Specification

500ml

Validity Period

Soda-lime glass infusion bottles, tentatively 18 months; three-layer co-extruded infusion bags, 24 months

Manufacturer

JiangSu ChiaTai FengHai Pharmaceutical Co., Ltd.

  • Founded in:

    1980-01-05
  • Address:

    No. 266, Nanxiang West Road, Dafeng District, Yancheng City, Jiangsu Province
  • Tax NO.:

    91320982134753235X
  • Registered Funds:

    $296,073,773,500
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.